81
50
Growth Score 81 in past quarter
-6 pts
Heat Score 50 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1444110
angioClast is a Cambridge biotech startup comitted to transform cancer research.
Minaam Abbas: Chief Operating Officer
Juba Tsuladze: CEO & Co-founder
About the Company
angioClast is a Cambridge biotech startup comitted to transform cancer research. Through the application of de novo markers of cancer blood vessels, angioClast strives to develop and revolutionize the treatment and diagnosis of various cancer types.

